Rapamycin exerts its geroprotective effects in the ageing human immune system by enhancing resilience against DNA damage
Loren Kell, Eleanor J. Jones, Nima Gharahdaghi, Daniel James Wilkinson, Kenneth Smith, Philip J Atherton, Anna Katharina Simon, Lynne S. Cox, Ghada Alsaleh
This study shows that rapamycin improves genome stability in aged human immune cells by reducing DNA damage, enhancing cell survival, and decreasing senescence markers.
Aging Cell · Jan 12, 2026Peer-reviewedImmunology